171 related articles for article (PubMed ID: 33492471)
1. Effect of iodinated contrast material on post-operative eGFR when administered during renal mass ablation.
Curci NE; Triche BL; Abel EJ; Bhutani G; Maciolek KA; Dreyfuss LD; Allen GO; Caoili EM; Davenport MS; Wells SA
Eur Radiol; 2021 Aug; 31(8):5490-5497. PubMed ID: 33492471
[TBL] [Abstract][Full Text] [Related]
2. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced CT immediately following percutaneous microwave ablation of cT1a renal cell carcinoma: Optimizing cancer outcomes.
Koebe SD; Curci NE; Caoili EM; Triche BL; Dreyfuss LD; Allen GO; Brace CL; Davenport MS; Abel EJ; Wells SA
Abdom Radiol (NY); 2022 Aug; 47(8):2674-2680. PubMed ID: 35278110
[TBL] [Abstract][Full Text] [Related]
4. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.
Klapperich ME; Abel EJ; Ziemlewicz TJ; Best S; Lubner MG; Nakada SY; Hinshaw JL; Brace CL; Lee FT; Wells SA
Radiology; 2017 Jul; 284(1):272-280. PubMed ID: 28076721
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
6. CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation.
Wetley KA; Abel EJ; Dreyfuss LD; Huang W; Brace CL; Wells SA
Abdom Radiol (NY); 2020 Sep; 45(9):2810-2824. PubMed ID: 32715335
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
8. Microwave Thermal Ablation versus Open Partial Nephrectomy for the Treatment of Small Renal Tumors in Patients Over 70 Years Old.
Anglickis M; Anglickienė G; Andreikaitė G; Skrebūnas A
Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31581459
[No Abstract] [Full Text] [Related]
9. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
[TBL] [Abstract][Full Text] [Related]
10. RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome.
Park BK; Gong IH; Kang MY; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
Eur Radiol; 2018 Jul; 28(7):2979-2985. PubMed ID: 29426988
[TBL] [Abstract][Full Text] [Related]
11. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
Zhou W; Arellano RS
J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients.
Yu J; Zhang X; Liu H; Zhang R; Yu X; Cheng Z; Han Z; Liu F; Hao G; Mu MJ; Liang P
Radiology; 2020 Mar; 294(3):698-706. PubMed ID: 31961239
[TBL] [Abstract][Full Text] [Related]
13. Risk Assessment of Chronic Kidney Disease following Microwave Ablation for Stage T1 Renal Cell Carcinoma.
Zhou W; Herwald SE; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2018 Dec; 29(12):1685-1691. PubMed ID: 30297311
[TBL] [Abstract][Full Text] [Related]
14. Microwave ablation of cT1a renal cell carcinoma: oncologic and functional outcomes at a single center.
Wilcox Vanden Berg RN; Calderon LP; LaRussa S; Enobakhare O; Craig K; Del Pizzo J; McClure TD
Clin Imaging; 2021 Aug; 76():199-204. PubMed ID: 33964597
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
[TBL] [Abstract][Full Text] [Related]
17. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
Yu J; Wang H; Cheng ZG; Liu FY; Li QY; He GZ; Luo YC; Yu XL; Han ZY; Liang P
Eur Radiol; 2022 Jan; 32(1):89-100. PubMed ID: 34195888
[TBL] [Abstract][Full Text] [Related]
18. Renal mass biopsy and thermal ablation: should biopsy be performed before or during the ablation procedure?
Wells SA; Wong VK; Wittmann TA; Lubner MG; Best SL; Ziemlewicz TJ; Hinshaw JL; Lee FT; Abel EJ
Abdom Radiol (NY); 2017 Jun; 42(6):1773-1780. PubMed ID: 28184961
[TBL] [Abstract][Full Text] [Related]
19. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency Ablation of T1a Renal Cell Carcinomas within Renal Transplant Allografts: Oncologic Outcomes and Graft Viability.
Cool DW; Kachura JR
J Vasc Interv Radiol; 2017 Dec; 28(12):1658-1663. PubMed ID: 28916346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]